Quality of Life Assessment has progressed considerably since the publication of the first highly acclaimed edition of this book in 1998. Quality of life has now become an indispensable outcome measure in many randomised clinical trials and other studies. Thus, it is timely to provide not just an update, but a completely new edition that reviews the current state of art and also discusses topical issues including areas where active research is in progress. The first section discusses the development and evaluation of generic and disease-targeted questionnaires. Having decided the items to be included the thrust of the next section covers how to convert these into usable forms. Section 3 addressing analysis and the methods of analysing studies with missing data is followed by chapters on interpretation of results and exploring the role of single-item questions. The final section of the book looks beyond the individual clinical trial and how we can use clinical trial and other data to make macro-decisions.
A strong international team of experts cover a wide range of topics, emphasizing new and innovative approaches that are of practical and clinical importance, reviewing the current state of the art and illustrating the benefits and potential of health related quality of life assessment in clinical trials.
Publisher: Oxford University Press
Number of pages: 488
Weight: 931 g
Dimensions: 248 x 175 x 32 mm
Edition: 2nd Revised edition
This book is clearly written, resource-rich, and eloquently blends both traditional and innovative approaches to measuring HRQoL in clinical trials... Fayers and Hays' new edition encapsulates the essential and highly regarded notion of patient-centered care and will prove to be an outstanding addition to any clinical researcher's library. * Quality of Life Research, Vol 15 *
This excellently presented book achieves its aims of being an introduction to QoL, and its assessment, analysis, and interpretation. * International Journal of Epidemiology, Vol 34, No. 6 *
This book represents a comprehensive overview of the field with contributions from 31 authors, in a collection of 24 chapters. The objective of this book is to provide a thorough review of the current state of the art methodology. The objective is whole-heartedly achieved through its six sections. * Journal of Biopharmaceutical Statistics *